VeriSee DR, AI-assisted Diagnostic Software for Diabetic Retinopathy (DR): The software is intended for use on color fundus images of adults (20 years of age or older) diagnosed with diabetes. The product uses AI to provide suggestions for the classification of diabetic retinopathy (Regular tracking or Referral recommended) to assist healthcare providers in diagnosing DR. In addition, the product detects four main lesions of DR, including microaneurysms, hemorrhages, soft exudates (cotton-wool spots), and hard exudates, and shows the corresponding locations.
VeriSee AMD, AI-Assisted Screening Software for Aged-Related Macular Degeneration. The software uses AI to analyze the fundus image of individuals aged 50 and above to provide the assistance for healthcare providers in preliminary screening to determine whether patients meet the criteria of AMD level 3 or above on the AMD severity scale defined by the age-related eye disease study (AREDS).
VeriOsteo OP, AI-assisted screening software for BMD abnormality: AI-assisted screening software for BMD abnormality. AI-assisted screening software for BMD abnormalities. It analyzes spinal regions in routine chest X-ray images, estimates BMD values, and calculates T-scores to offer binary screening for BMD abnormalities.